Ticker brief

GNPX

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
3
crowd 14d
+1.5σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-25 · now +0.50 (−1 bearish … +1 bullish)
Who spoke3
authorgradetrader scoresignalsmean sent
@TT_stocks_C-0.675+0.72
@TheBreakoutZoneC+1.852+0.72
@ACInvestorBlogC-1.361+0.50
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-25@ACInvestorBlog+0.50Calls GNPX a high-risk value idea below cash with a potential bottom and oncology/diabetes optionality.·
2026-08-18@TheBreakoutZone+0.70Summarizes completed daily alert gains and one loss; output is capped at six tickers.·
2026-08-18@TT_stocks_+0.90Celebrates GNPX moving from the $4.40s to $7.52 after prior dip-buy recommendations.·
2026-08-18@TheBreakoutZone+0.75Promotes completed premarket calls with gains of 26%, 52%, and 60%.·
2026-08-17@TT_stocks_+0.30Reports GNPX reaching an after-hours high of 5.63.·
2026-08-17@TT_stocks_+0.75Argues low offering risk and limited overhead supply could allow a sustained algorithm-driven run.·
2026-08-17@TT_stocks_+0.85Presents a detailed long thesis based on cash, balance-sheet strength, clinical catalysts and possible fivefold upside.·
2026-08-17@TT_stocks_+0.80GNPX is a new long idea. — Explicitly introduces GNPX as a new long idea.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.